Literature DB >> 7679026

Neurokinin-induced changes in pial artery diameter in the anaesthetized guinea-pig.

D T Beattie1, C M Stubbs, H E Connor, W Feniuk.   

Abstract

1. The effects of selective neurokinin agents on pial artery diameter, measured with an on-line image analyser, have been studied in anaesthetized guinea-pigs in order to characterize the neurokinin receptors present on pial arteries. 2. Perivascular injection of either substance P (0.01-1 microM) or the selective NK1 receptor agonists, substance P methyl ester (SPOMe, 0.01-1 microM) and GR73632 (0.1 microM), increased pial artery diameter. 3. In contrast, the selective NK2 receptor agonist, GR64349 (1 microM), produced a small vasoconstriction while the NK3 receptor-selective agonist, senktide (1 microM) was inactive. 4. Co-administration of GR82334 (1 microM), a selective NK1 receptor antagonist, inhibited the vasodilatation produced by SPOMe (0.1 microM) but not that caused by calcitonin gene-related peptide (CGRP, 0.01 microM). 5. The results are consistent with an involvement of NK1 receptors in the neurokinin-induced increase in guinea-pig pial artery diameter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679026      PMCID: PMC1907708          DOI: 10.1111/j.1476-5381.1993.tb13454.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Calcitonin gene-related peptide coexists with substance P in capsaicin sensitive neurons and sensory ganglia of the rat.

Authors:  G Skofitsch; D M Jacobowitz
Journal:  Peptides       Date:  1985 Jul-Aug       Impact factor: 3.750

2.  Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins.

Authors:  P D'Orléans-Juste; S Dion; G Drapeau; D Regoli
Journal:  Eur J Pharmacol       Date:  1986-06-05       Impact factor: 4.432

3.  Characterization of a neurokinin B receptor site in rat brain using a highly selective radioligand.

Authors:  R Laufer; C Gilon; M Chorev; Z Selinger
Journal:  J Biol Chem       Date:  1986-08-05       Impact factor: 5.157

4.  In vitro release of immunoreactive substance P from putative afferent nerve endings in bovine pia arachnoid.

Authors:  M A Moskowitz; M Brody; L Y Liu-Chen
Journal:  Neuroscience       Date:  1983-08       Impact factor: 3.590

5.  Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater.

Authors:  L Edvinsson; S Rosendal-Helgesen; R Uddman
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

6.  Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats.

Authors:  L Y Liu-Chen; M R Mayberg; M A Moskowitz
Journal:  Brain Res       Date:  1983-05-23       Impact factor: 3.252

7.  Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ.

Authors:  L Edvinsson; J McCulloch; R Uddman
Journal:  J Physiol       Date:  1981-09       Impact factor: 5.182

8.  Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation.

Authors:  C M Stubbs; G J Waldron; H E Connor; W Feniuk
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

9.  Calcitonin gene-related peptide is a potent vasodilator.

Authors:  S D Brain; T J Williams; J R Tippins; H R Morris; I MacIntyre
Journal:  Nature       Date:  1985 Jan 3-9       Impact factor: 49.962

10.  The neurobiology of vascular head pain.

Authors:  M A Moskowitz
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

View more
  6 in total

1.  The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.

Authors:  D T Beattie; I J Beresford; H E Connor; F H Marshall; A B Hawcock; R M Hagan; J Bowers; P J Birch; P Ward
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  The influence of the trigeminal ganglion on carotid blood flow in anaesthetized guinea-pigs.

Authors:  D T Beattie; H E Connor
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

3.  Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva.

Authors:  W S Lee; S M Moussaoui; M A Moskowitz
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

4.  Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo.

Authors:  J M Hall; S D Brain
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

Review 5.  The Regulation of Pulmonary Vascular Tone by Neuropeptides and the Implications for Pulmonary Hypertension.

Authors:  Charmaine C W Lo; Seyed M Moosavi; Kristen J Bubb
Journal:  Front Physiol       Date:  2018-08-23       Impact factor: 4.566

6.  Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.

Authors:  Kate Marie Lewis; Renée Jade Turner; Robert Vink
Journal:  Int J Inflam       Date:  2013-05-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.